Form D · Biotechnology

BrainTrust BIO Inc.

Atlanta, GA · CIK 0001844575

Offering snapshot reported Jan 26, 2022 · SEC filing

Reported sold
$400K
Offering amount: $2M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 19, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$200K$400KMar 26, 2021: $50,000.00Mar 26, 2021Jan 26, 2022: $400,000.00Jan 26, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$50,000 → $400,000
  • Reported investors1 → 6

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 26, 2022Amendment$400,000$350,000vs Mar 26, 20216SEC filing
Mar 26, 2021Initial$50,000No comparison1SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-393734
Convertible promissory notes

Source: Form D, filed Jan 26, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Chen Benkler Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1447 Peachtree St. Ne
Atlanta, GA, 30309